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MAGNETO-RADIOTHERAPY: EFFECT OF MAGNETIC FIELD ON DOSE 
DISTRIBUTION & RBE 
H.Nettelbeck, A.Rosenfeld, G.Takacs and M.Lerch 
Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia. 
 
INTRODUCTION: Magneto-radiotherapy is the application of magnetic fields during 
radiotherapy procedures. It aims to improve the quality of cancer treatment by altering the 
dose deposition of charged particles in the tissue volume being targeted. Our research has 
focused on applying the concept of magneto-radiotherapy to conventional linac treatment and 
MRT (Microbeam Radiation Therapy) oncology modalities. 
METHODS: We have used a combination of Monte Carlo (MC) simulations and physical 
measurements to investigate the effect of a magnetic field on the dose distribution by 
secondary electrons from primary photon beams. Two magnetic field orientations were used 
to investigate this effect: longitudinal magnetic fields (where the direction of field is parallel 
to the beam axis), and transverse magnetic fields (where direction of field is along a plane 
perpendicular to beam axis). MC (PENELOPE) simulations have been done to ensure 
modified PENELOPE code can accurately reproduce: measured data for a 6-MV linac beam 
(i.e. dose-profiles and depth-dose curves) in the absence of a magnetic field; and published 
magneto-RT results in the presence of a magnetic field. Measurements for magneto-MRT, 
investigating the effect of a static 1T magnetic field on the Peak to Valley Dose Ratios 
(PVDRs) of the MRT microbeam-array with depth, are scheduled for early October 2005 at 
ESRF (European Synchrotron Research Facility). A comparison of these measurements with 
results from a MC study of PVDRs with depth will be conducted. 
RESULTS: A strong longitudinal magnetic field reduces lateral scattering of secondary 
electrons causing a narrowing of the beam penumbra in the plane perpendicular to beam axis. 
A strong transverse magnetic field forces the charged particles into helical trajectories about 
the field direction, producing a confined beam penumbra with depth. The therapeutic 
advantage of using either magnetic field orientation is that both confine the dose-deposition 
of secondary electrons to produce regions of dose-enhancement and dose-reduction that can 
be aligned with tumour and healthy tissue regions, respectively. Below is a comparison of the 
dose-perturbation we obtained with MC simulation of a transverse magnetic field applied to a 
6-MV linac beam (fig.1), to that obtained by Li, et al.1 with a 15-MV beam (fig. 2). 
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DISCUSSION & CONCLUSIONS: Incorporating magnetic fields into current oncology 
modalities promises a number of therapeutic benefits, the most obvious being a dose 
enhancement in the tumour tissue and dose-reduction in adjacent healthy tissue. Magneto-RT 
has the potential to alleviate problems in cancer treatment such as the treatment of tumours 
close to critical structures. Radiobiological effects have never been investigated for magneto 
RT. We will carry out MC simulations to obtain the low-energy secondary electron spectra of 
photon radiation beams to examine the radiobiological effects, in particular, RBE (Relative 
Biological Effectiveness) of magneto-RT applications. 
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